Evidence map›Paper›PMID 39753362›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

Mathematic Modeling of Tumor Growth During [

Nouran R R Zaid, Remco Bastiaannet, Rob Hobbs, George Sgouros

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Beyond [BMC cancer · 2026
    Pooled it
  2. Applications of artificial intelligence in nuclear medicine.Zeitschrift fur medizinische Physik · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nouran R R ZaidDepartment of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and nzaid1@jh.edu.
Remco BastiaannetDepartment of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and.
Rob HobbsDepartment of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and.
George SgourosDepartment of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; and.

Funding

Radiobioeffect Modeling of αRPTP01CA272222 · NCI · JOHNS HOPKINS UNIVERSITY · PI Ana Ponce Kiess · 2023 to 2026
$12.8M
Dose-Response in Radionuclide TherapyR01CA116477 · NCI · JOHNS HOPKINS UNIVERSITY · PI HOBBS, ROBERT FRANCOIS, SGOUROS, GEORGE · 2006 to 2022
$7.1M
Combination Radiopharmaceutical Therapy and External Beam RadiotherapyR01CA240779 · NCI · JOHNS HOPKINS UNIVERSITY · PI HOBBS, ROBERT FRANCOIS, LADENSON, PAUL W · 2020 to 2025
$2.8M
NCI NIH HHS P01 CA272222NCI NIH HHS R01 CA116477NCI NIH HHS R01 CA240779
6 · The paper itself

Abstract

The treatment regimen for [

Indexed as

DipeptidesLutetiumCell ProliferationHeterocyclic Compounds, 1-RingHumansMaleModels, BiologicalProstate-Specific AntigenProstatic NeoplasmsRadioisotopesRadiopharmaceuticalsDipeptidesHeterocyclic Compounds, 1-RingLutetiumLutetium-177PluvictoProstate-Specific AntigenPSMA-617RadioisotopesRadiopharmaceuticals[177Lu]Lu-PSMA therapyGompertz tumor growthpharmacokineticsradiobiological modelingtreatment optimization

Identifiers

PMID39753362
PMCPMC11705791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.